Product
Ceftolozane/tazobactam
2 clinical trials
6 indications
Indication
BronchiectasisIndication
Cystic FibrosisIndication
Pseudomonas aeruginosaIndication
Burkholderia cepacia infectionIndication
Hematologic NeoplasmsIndication
NeutropeniaClinical trial
The Feasibility of Ceftolozane/Tazobactam Continuous Infusion for Exacerbations of Cystic Fibrosis and Bronchiectasis Treated in an Outpatient Parenteral Antibiotic Therapy (OPAT) SettingStatus: Not yet recruiting, Estimated PCD: 2023-10-01
Clinical trial
Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia Due to Enterobacteriaceae and Pseudomonas Aeruginosa in Hemato-oncological Patients With Severe Neutropenia and Fever: Non-inferiority StudyStatus: Recruiting, Estimated PCD: 2025-07-31